Skip to content

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors

The Time is Now”. CEO Ilan Sobel explains North American Cannabis Entry Strategy

← Previous Media Video

Next Media Video →

Search

Recent Posts

BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026

Recent Comments

No comments to show.

Archives

Categories

2020
2021
2022
2023
2024
2025
2026
Uncategorized

Join Our Newsletter

Be the first to receive our news alerts, event notifications, and product releases.

Revolution

Facebook X-twitter Linkedin Youtube

About
- Technology
- Our Team
- Contact
- FAQ
Therapeutic Solutions
- Nutraceuticals
- CDMO Services
Our Competitive Advantage
- Clinical Studies
- Sustainability
News
Investors